Related Experiment Video
Updated: Aug 16, 2026
07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Use of proteomic patterns as a novel screening tool in pre-eclampsia
Jenny Myers1, Maureen Macleod, B Reed
1Maternal and Fetal Health Research Centre, St Mary's Hospital, University of Manchester, Manchester, UK. jenny.myers@man.ac.uk
Summary
This pilot study identified five up-regulated proteins in plasma at 26 weeks in women who developed pre-eclampsia. These protein profile differences may aid in early pre-eclampsia detection for at-risk pregnancies.
Area of Science:
- Biochemistry
- Proteomics
- Maternal-Fetal Medicine
Background:
- Pre-eclampsia is a serious pregnancy complication.
- Early detection of pre-eclampsia is crucial for maternal and fetal well-being.
- Identifying reliable biomarkers for pre-eclampsia risk is an ongoing research area.
Purpose of the Study:
- To investigate protein profile differences in plasma from women at risk of pre-eclampsia.
- To identify potential protein biomarkers for predicting pre-eclampsia development.
Main Methods:
- Utilized Ciphergen ProteinChip technology for proteomic analysis.
- Analyzed plasma samples collected at 26 weeks gestation.
- Compared protein profiles between women who developed pre-eclampsia and normotensive controls.
Main Results:
- Identified five proteins that were significantly up-regulated in women who developed pre-eclampsia.
- These protein alterations were observed at 26 weeks gestation.
Conclusions:
- Protein profiling may offer a method for early pre-eclampsia risk assessment.
- The identified up-regulated proteins warrant further investigation as potential biomarkers.
